thrombin receptor peptide sfllrnp has been researched along with bradykinin in 2 studies
| Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 92 | 10 | 29 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | thrombin receptor peptide sfllrnp (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tesfamariam, B | 1 |
| Biaggioni, I; Brown, NJ; Byrne, DW; Luther, JM; Malave, HA; Murphey, LJ; Petro, J; Pretorius, M; Vaughan, DE | 1 |
2 other study(ies) available for thrombin receptor peptide sfllrnp and bradykinin
| Article | Year |
|---|---|
Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amino Acid Sequence; Animals; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Kinetics; Molecular Sequence Data; Muscle Relaxation; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Prostaglandin Endoperoxides, Synthetic; Receptors, Thrombin; Serotonin; Substance P; Swine; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
Topics: Adult; Bradykinin; Dose-Response Relationship, Drug; Female; Fetus; Fibrinolysis; Humans; Male; Peptide Fragments; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 2006 |